GRAIL, Inc. balance sheet GRAL

Annual Quarterly

As of Jun 30, 2026, GRAIL, Inc. had total assets of $2.8 billion and total liabilities of $301.0 million. Total assets were up 5.2% from a year earlier. Stockholders' equity was $2.5 billion. It held $55.6 million in cash and investments against $91.3 million of total debt, net debt of $35.7 million. The current ratio, current assets divided by current liabilities, was 10.95.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Assets
Cash
56
-56.3%
69
-48.2%
250
+16.6%
127
-85.1%
127
-86.7%
134
214
854
Cash and investments
56
-56.3%
69
-48.2%
250
+16.6%
127
-85.1%
127
-86.7%
134
214
854
Receivables
20
+21.1%
20
+5.4%
18
-9.9%
16
16
19
20
—
Total current assets
915
+40.3%
877
+20.6%
954
+16.3%
589
-35.2%
652
-36.0%
728
820
910
Property and equipment, net
44
-26.4%
48
-25.9%
52
-25.0%
56
60
65
69
—
Goodwill
—
—
—
—
—
—
0
0
Total assets
2,844
+5.2%
2,803
-1.5%
2,922
-2.1%
2,601
-16.6%
2,703
-17.3%
2,848
2,983
3,118
Liabilities and equity
Accounts payable
7
+15.2%
5
-19.1%
2
-57.0%
3
6
6
5
—
Total current liabilities
84
+18.3%
75
-0.4%
80
+3.6%
77
-17.9%
71
-19.9%
75
77
94
Total liabilities
301
-22.4%
303
-30.2%
344
-28.3%
361
-31.9%
388
-32.5%
434
480
530
Stockholders' equity
2,543
+9.9%
2,501
+3.6%
2,578
+3.0%
2,240
-13.4%
2,315
-14.1%
2,414
2,503
2,588
Debt
Lease liabilities
91
+46.9%
51
-20.7%
55
-19.5%
59
-18.8%
62
-18.3%
64
68
72
Total debt
91
+46.9%
51
-20.7%
55
-19.5%
59
-18.8%
62
-18.3%
64
68
72
Net cash
-36
-154.6%
18
-73.7%
195
+33.4%
68
-91.3%
65
-92.6%
70
146
781
Ratios
Current ratio
10.95x
11.74x
11.97x
7.61x
9.23x
9.71x
10.66x
9.65x
Debt to equity
0.04x
0.02x
0.02x
0.03x
0.03x
0.03x
0.03x
0.03x
Return on equity
-15.40%
-15.81%
-15.84%
-18.14%
-19.14%
—
-80.97%
—
Return on assets
-13.77%
-14.10%
-13.97%
-15.62%
-16.39%
—
-67.94%
—
Book value per share
56.93
60.79
—
61.94
64.21
68.38
73.86
77.93
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
GRAL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Sunnyvale, CA
SEC filer status
, Emerging growth company
SEC CIK
1699031
Former names
GRAIL, LLC (until Jun 12, 2024)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.